Investors

“Arthro Kinetics has developed an exciting range of biologic implants which we believe will set new standards of surgical care, and provide significant benefits to patients by making knee joint and nucleus disc regeneration a viable option. We look forward to creating value for shareholders as we implement our international growth strategy.” Jason Loveridge, Chief Executive Officer of Arthro Kinetics plc.

Contacts
Douglas Quinn
CFO, Arthro Kinetics Ltd
d.quinn@arthro-kinetics.com